• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用人源拓扑异构酶连接域替换疟原虫同源物可使酶对喜树碱产生抗性。

Replacement of the human topoisomerase linker domain with the plasmodial counterpart renders the enzyme camptothecin resistant.

机构信息

Department of Biology and Interuniversity Consortium, National Institute Biostructure and Biosystem, University of Rome Tor Vergata, Rome, Italy.

出版信息

PLoS One. 2013 Jul 2;8(7):e68404. doi: 10.1371/journal.pone.0068404. Print 2013.

DOI:10.1371/journal.pone.0068404
PMID:23844196
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3699648/
Abstract

A human/plasmodial hybrid enzyme, generated by swapping the human topoisomerase IB linker domain with the corresponding domain of the Plasmodium falciparum enzyme, has been produced and characterized. The hybrid enzyme displays a relaxation activity comparable to the human enzyme, but it is characterized by a much faster religation rate. The hybrid enzyme is also camptothecin resistant. A 3D structure of the hybrid enzyme has been built and its structural-dynamical properties have been analyzed by molecular dynamics simulation. The analysis indicates that the swapped plasmodial linker samples a conformational space much larger than the corresponding domain in the human enzyme. The large linker conformational variability is then linked to important functional properties such as an increased religation rate and a low drug reactivity, demonstrating that the linker domain has a crucial role in the modulation of the topoisomerase IB activity.

摘要

一种人/疟原虫杂种酶,通过将人拓扑异构酶 IB 连接域与疟原虫 falciparum 酶的相应结构域交换而产生并进行了特性分析。杂种酶显示出与人类酶相当的松弛活性,但它的重新连接速率要快得多。杂种酶也对喜树碱具有抗性。杂种酶的三维结构已经建立,并通过分子动力学模拟对其结构-动力学特性进行了分析。分析表明,交换的疟原虫连接子可以采样比人酶中相应结构域更大的构象空间。较大的连接子构象可变性与重要的功能特性相关,例如增加的重新连接率和低药物反应性,表明连接子结构域在拓扑异构酶 IB 活性的调节中起着关键作用。

相似文献

1
Replacement of the human topoisomerase linker domain with the plasmodial counterpart renders the enzyme camptothecin resistant.用人源拓扑异构酶连接域替换疟原虫同源物可使酶对喜树碱产生抗性。
PLoS One. 2013 Jul 2;8(7):e68404. doi: 10.1371/journal.pone.0068404. Print 2013.
2
A functional linker in human topoisomerase I is required for maximum sensitivity to camptothecin in a DNA relaxation assay.在DNA松弛试验中,人拓扑异构酶I中的功能性连接子是对喜树碱产生最大敏感性所必需的。
J Biol Chem. 1999 Nov 12;274(46):32950-60. doi: 10.1074/jbc.274.46.32950.
3
Molecular mechanism of the camptothecin resistance of Glu710Gly topoisomerase IB mutant analyzed in vitro and in silico.体外和计算机模拟分析 Glu710Gly 拓扑异构酶 IB 突变体的喜树碱耐药的分子机制。
Mol Cancer. 2013 Sep 3;12(1):100. doi: 10.1186/1476-4598-12-100.
4
The human topoisomerase 1B Arg634Ala mutation results in camptothecin resistance and loss of inter-domain motion correlation.人类拓扑异构酶1B的精氨酸634突变为丙氨酸会导致对喜树碱产生抗性,并丧失结构域间运动相关性。
Biochim Biophys Acta. 2013 Dec;1834(12):2712-21. doi: 10.1016/j.bbapap.2013.09.017. Epub 2013 Oct 2.
5
Single mutation in the linker domain confers protein flexibility and camptothecin resistance to human topoisomerase I.连接域中的单个突变赋予人类拓扑异构酶I蛋白质灵活性和喜树碱抗性。
J Biol Chem. 2003 Oct 31;278(44):43268-75. doi: 10.1074/jbc.M303899200. Epub 2003 Aug 6.
6
Mutation of Gly717Phe in human topoisomerase 1B has an effect on enzymatic function, reactivity to the camptothecin anticancer drug and on the linker domain orientation.人类拓扑异构酶1B中Gly717Phe的突变对酶功能、对喜树碱抗癌药物的反应性以及连接域方向有影响。
Biochim Biophys Acta. 2015 Aug;1854(8):860-8. doi: 10.1016/j.bbapap.2015.04.017. Epub 2015 Apr 22.
7
Structural insights into the function of type IB topoisomerases.对IB型拓扑异构酶功能的结构见解。
Curr Opin Struct Biol. 1999 Feb;9(1):29-36. doi: 10.1016/s0959-440x(99)80005-0.
8
A pentapeptide signature motif plays a pivotal role in Leishmania DNA topoisomerase IB activity and camptothecin sensitivity.一个五肽特征基序在利什曼原虫DNA拓扑异构酶IB活性和喜树碱敏感性中起关键作用。
Biochim Biophys Acta. 2012 Dec;1820(12):2062-71. doi: 10.1016/j.bbagen.2012.09.005. Epub 2012 Sep 18.
9
Expression of human topoisomerase I with a partial deletion of the linker region yields monomeric and dimeric enzymes that respond differently to camptothecin.具有连接区部分缺失的人拓扑异构酶I的表达产生了对喜树碱有不同反应的单体和二聚体酶。
J Biol Chem. 2000 Aug 18;275(33):25820-30. doi: 10.1074/jbc.M002144200.
10
An engineered mutant of vaccinia virus DNA topoisomerase I is sensitive to the anti-cancer drug camptothecin.痘苗病毒DNA拓扑异构酶I的一种工程突变体对抗癌药物喜树碱敏感。
J Biol Chem. 1992 Dec 5;267(34):24177-80.

引用本文的文献

1
A tale of topoisomerases and the knotty genetic material in the backdrop of Plasmodium biology.拓扑异构酶与疟原虫生物学背景下复杂的遗传物质的故事。
Biosci Rep. 2022 Jun 30;42(6). doi: 10.1042/BSR20212847.
2
Topoisomerase IB: a relaxing enzyme for stressed DNA.拓扑异构酶IB:一种缓解DNA压力的松弛酶。
Cancer Drug Resist. 2020 Mar 19;3(1):18-25. doi: 10.20517/cdr.2019.106. eCollection 2020.
3
Topoisomerase I (TOP1) dynamics: conformational transition from open to closed states.拓扑异构酶 I(TOP1)动力学:从开放状态到闭合状态的构象转变。

本文引用的文献

1
GROMACS 4:  Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation.GROMACS 4:高效、负载均衡和可扩展的分子模拟算法。
J Chem Theory Comput. 2008 Mar;4(3):435-47. doi: 10.1021/ct700301q.
2
Binding of an Indenoisoquinoline to the topoisomerase-DNA complex induces reduction of linker mobility and strengthening of protein-DNA interaction.吲哚异喹啉与拓扑异构酶-DNA 复合物的结合诱导连接子流动性的降低和蛋白质-DNA 相互作用的增强。
PLoS One. 2012;7(12):e51354. doi: 10.1371/journal.pone.0051354. Epub 2012 Dec 6.
3
Droplet microfluidics platform for highly sensitive and quantitative detection of malaria-causing Plasmodium parasites based on enzyme activity measurement.
Nat Commun. 2022 Jan 10;13(1):59. doi: 10.1038/s41467-021-27686-7.
4
In Vitro and In Silico Characterization of an Antimalarial Compound with Antitumor Activity Targeting Human DNA Topoisomerase IB.体外和计算机模拟研究具有抗肿瘤活性的抗疟化合物对人 DNA 拓扑异构酶 IB 的作用。
Int J Mol Sci. 2021 Jul 12;22(14):7455. doi: 10.3390/ijms22147455.
5
Swapping of The N-Terminal Domain of Human Topoisomerase 1B with the Corresponding Counterpart Strongly Impairs Enzyme Activity.将人类拓扑异构酶1B的N端结构域与相应的对应结构域进行交换会严重损害酶的活性。
Rep Biochem Mol Biol. 2020 Jan;8(4):366-375.
6
DNA topoisomerase I domain interactions impact enzyme activity and sensitivity to camptothecin.DNA拓扑异构酶I结构域相互作用影响酶活性及对喜树碱的敏感性。
J Biol Chem. 2015 May 8;290(19):12068-78. doi: 10.1074/jbc.M114.635078. Epub 2015 Mar 20.
7
Simulations of DNA topoisomerase 1B bound to supercoiled DNA reveal changes in the flexibility pattern of the enzyme and a secondary protein-DNA binding site.与超螺旋DNA结合的DNA拓扑异构酶1B的模拟揭示了该酶灵活性模式的变化以及一个二级蛋白质-DNA结合位点。
Nucleic Acids Res. 2014 Aug;42(14):9304-12. doi: 10.1093/nar/gku654. Epub 2014 Jul 23.
8
Theoretical and experimental studies of new modified isoflavonoids as potential inhibitors of topoisomerase I from Plasmodium falciparum.新型修饰异黄酮作为恶性疟原虫拓扑异构酶I潜在抑制剂的理论与实验研究
PLoS One. 2014 Mar 20;9(3):e91191. doi: 10.1371/journal.pone.0091191. eCollection 2014.
9
Molecular mechanism of the camptothecin resistance of Glu710Gly topoisomerase IB mutant analyzed in vitro and in silico.体外和计算机模拟分析 Glu710Gly 拓扑异构酶 IB 突变体的喜树碱耐药的分子机制。
Mol Cancer. 2013 Sep 3;12(1):100. doi: 10.1186/1476-4598-12-100.
基于酶活性测量的用于高灵敏定量检测疟原虫的液滴微流控平台。
ACS Nano. 2012 Dec 21;6(12):10676-83. doi: 10.1021/nn3038594. Epub 2012 Nov 7.
4
Interaction between natural compounds and human topoisomerase I.天然化合物与人体拓扑异构酶 I 的相互作用。
Biol Chem. 2012 Nov;393(11):1327-40. doi: 10.1515/hsz-2012-0240.
5
Role of Flexibility in Protein-DNA-Drug Recognition: The Case of Asp677Gly-Val703Ile Topoisomerase Mutant Hypersensitive to Camptothecin.灵活性在蛋白质-DNA-药物识别中的作用:以对喜树碱高度敏感的Asp677Gly-Val703Ile拓扑异构酶突变体为例。
J Amino Acids. 2012;2012:206083. doi: 10.1155/2012/206083. Epub 2012 Jan 19.
6
Mutagenic processing of ribonucleotides in DNA by yeast topoisomerase I.酵母拓扑异构酶 I 对 DNA 中核糖核苷酸的诱变处理。
Science. 2011 Jun 24;332(6037):1561-4. doi: 10.1126/science.1205016.
7
Structural and dynamical effects induced by the anticancer drug topotecan on the human topoisomerase I - DNA complex.拓扑替康对人拓扑异构酶 I-DNA 复合物的结构和动力学影响。
PLoS One. 2010 Jun 3;5(6):e10934. doi: 10.1371/journal.pone.0010934.
8
DNA topoisomerases in apicomplexan parasites: promising targets for drug discovery.顶体酶在顶复门寄生虫中的作用:药物研发的有前途的靶点。
Proc Biol Sci. 2010 Jun 22;277(1689):1777-87. doi: 10.1098/rspb.2009.2176. Epub 2010 Mar 3.
9
Evidence of the crucial role of the linker domain on the catalytic activity of human topoisomerase I by experimental and simulative characterization of the Lys681Ala mutant.通过对Lys681Ala突变体的实验和模拟表征,证明连接子结构域对人拓扑异构酶I催化活性的关键作用。
Nucleic Acids Res. 2009 Nov;37(20):6849-58. doi: 10.1093/nar/gkp669. Epub 2009 Sep 18.
10
DNA topoisomerase I inhibitors: chemistry, biology, and interfacial inhibition.DNA拓扑异构酶I抑制剂:化学、生物学及界面抑制
Chem Rev. 2009 Jul;109(7):2894-902. doi: 10.1021/cr900097c.